Javier Martín‐Escolano

Insights into Chagas treatment based on the potential of bacteriocin AS-48

Rubén Martín‐Escolano, Rubén Cebrián, Javier Martín‐Escolano et al. · International Journal for Parasitology Drugs and Drug Resistance · 2019 · 27 citations · Full text

Selenium Derivatives as Promising Therapy for Chagas Disease: <i>In Vitro</i> and <i>In Vivo</i> Studies

Rubén Martín‐Escolano, Mikel Etxebeste-Mitxeltorena, Javier Martín‐Escolano et al. · ACS Infectious Diseases · 2021 · 18 citations · Full text

New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases

Rubén Martín‐Escolano, Daniel Molina-Carreño, Estefanía Delgado‐Pinar et al. · European Journal of Medicinal Chemistry · 2018 · 16 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Pharmacological Study +9

Synthesis and Biological in vitro and in vivo Evaluation of 2‐(5‐Nitroindazol‐1‐yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease

Rubén Martín‐Escolano, Benjamín Aguilera‐Venegas, Álvaro Martín‐Montes et al. · ChemMedChem · 2018 · 15 citations · Full text

In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis

Rubén Martín‐Escolano, Juan J. Guardia, Javier Martín‐Escolano et al. · Journal of Natural Products · 2020 · 14 citations · Full text